Herman F. Staats focuses on Immunology, Virology, Cholera toxin, Nasal administration and Immune system. His study in Spleen, Immunity, Antibody, Immunization and Toxoid falls within the category of Immunology. The concepts of his Antibody study are interwoven with issues in Alphavirus and Venezuelan equine encephalitis virus.
His Virology study combines topics in areas such as Mucosal vaccine, Systemic immunity, Mucosal immunity and T-cell receptor. His studies in Cholera toxin integrate themes in fields like Cellular immunity and Adjuvant. Herman F. Staats works mostly in the field of Immune system, limiting it down to topics relating to Lymphocyte and, in certain cases, Mast cell, Pathology, Lymph, Tumor necrosis factor alpha and Proinflammatory cytokine.
His primary scientific interests are in Immunology, Immune system, Adjuvant, Antibody and Virology. In most of his Immunology studies, his work intersects topics such as Cholera toxin. His studies deal with areas such as Cytokine and Lymph node as well as Immune system.
His Adjuvant research includes themes of Mast cell, Immunogen, Compound 48/80 and Bacterial vaccine. His research in the fields of Immunoglobulin G, Immunoglobulin A and Humoral immunity overlaps with other disciplines such as Anthrax vaccines. Herman F. Staats focuses mostly in the field of Virology, narrowing it down to matters related to Mucosal vaccine and, in some cases, T-cell receptor, Systemic immunity and Mucosal immunity.
The scientist’s investigation covers issues in Immunology, Adjuvant, Vaccination, Antigen and Immune system. His work is connected to Antibody, Immunization, Immunogenicity, Mast cell and Anaphylaxis, as a part of Immunology. Vaccination is a subfield of Virology that Herman F. Staats explores.
His work carried out in the field of Virology brings together such families of science as Vaccines Administered and Serology. His Antigen study incorporates themes from Immunoglobulin E, Compound 48/80 and Antibody titer. He focuses mostly in the field of Immune system, narrowing it down to topics relating to Receptor and, in certain cases, Lymph and Connective tissue.
His primary scientific interests are in Immunology, Antibody, Immune system, Antigen and Adjuvant. His biological study spans a wide range of topics, including HIV vaccine and In vivo. His research in HIV vaccine tackles topics such as Virology which are related to areas like Immunization.
His Immune system research incorporates elements of Lymph, HEK 293 cells, Receptor, Activator and Cell type. His research in Antigen intersects with topics in Immunoglobulin E, Mannose receptor, Degranulation and Anaphylaxis. His Adjuvant research integrates issues from Compound 48/80 and Antigen-presenting cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Barton F. Haynes;Judith Fleming;E. William St. Clair;Herman Katinger.
Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
J Xu-Amano;H Kiyono;R J Jackson;H F Staats.
Journal of Experimental Medicine (1993)
Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.
M Marinaro;H F Staats;T Hiroi;R J Jackson.
Journal of Immunology (1995)
Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella.
J L VanCott;H F Staats;D W Pascual;M Roberts.
Journal of Immunology (1996)
Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection.
James B McLachlan;Justin P Hart;Salvatore V Pizzo;Christopher P Shelburne.
Nature Immunology (2003)
Mucosal immunity to infection with implications for vaccine development
Herman F Staats;Herman F Staats;Herman F Staats;Raymond J Jackson;Raymond J Jackson;Raymond J Jackson;Mariarosaria Marinaro;Mariarosaria Marinaro;Mariarosaria Marinaro;Ichiro Takahashi;Ichiro Takahashi;Ichiro Takahashi.
Current Opinion in Immunology (1994)
Mast cell activators: a new class of highly effective vaccine adjuvants
James B McLachlan;Christopher P Shelburne;Justin P Hart;Salvatore V Pizzo.
Nature Medicine (2008)
Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
H F Staats;W G Nichols;T J Palker.
Journal of Immunology (1996)
Mast cell–derived particles deliver peripheral signals to remote lymph nodes
Christian A. Kunder;Ashley L. St. John;Guojie Li;Kam W. Leong.
Journal of Experimental Medicine (2009)
Altered immune responses in apolipoprotein E-deficient mice.
D.T. Laskowitz;D.M. Lee;D. Schmechel;H.F. Staats.
Journal of Lipid Research (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: